We believe in helping people who are struggling
with serious and debilitating diseases.
Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses.Learn about our work
Many people living with amyotrophic lateral
sclerosis (ALS) have unmet medical needs.
We are committed to doing our best to find
solutions that may help address those needs.
Important news about our latest
developments in science & medicine.
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics
Announce U.S. Licensing and Supply Deal for Riluzole
Oral Film for ALS Treatment
Mitsubishi Tanabe Pharma America Announces Enhancements to
Out-of-Pocket Assistance Program for Eligible ALS Patients
Treated with Edaravone
Mitsubishi Tanabe Pharma America Honors Third Anniversary of ALS Treatment in the U.S. & Company’s Support of ALS CommunityRead More Aug 06, 2020